Mannucci P M, Moia M
Scuola di Specializzazione in Ematologia clinica, Cattedra di Patologia medica, Università, Milano.
Recenti Prog Med. 1991 Jan;82(1):31-4.
Deep vein thrombosis (DVT) of the limbs is a common event that may cause disability or even death. Of the triad of Virchow, which indicates the pathogenic factors involved in DVT, hypercoagulability is very important. The clinical diagnosis of DVT is not reliable and needs objective confirmation before a therapeutic decision can be made. Phlebography is still considered the treatment of choice for DVT diagnosis. Non invasive, less expensive diagnostic procedures have become available: among these, real time B-mode ultrasonography is the most promising. Laboratory tests are essentially non-specific and of little help in DVT diagnosis: they are essential to monitor anticoagulant therapy however, and to screen for congenital disorders that predispose to thrombosis. Therapy of DVT is based on the correct use of heparin and oral anticoagulants: only a few patients should be treated with thrombolytic drugs. Low-dose heparin is considered the most effective treatment for post-surgical DVT prevention and should be more widely used. New low molecular weight heparins have proven to be more efficacious and safe in DVT prophylaxis after orthopedic surgery.
肢体深静脉血栓形成(DVT)是一种常见病症,可能导致残疾甚至死亡。在表明DVT致病因素的Virchow三联征中,血液高凝状态非常重要。DVT的临床诊断不可靠,在做出治疗决策前需要客观证实。静脉造影术仍被视为DVT诊断的首选方法。已出现了非侵入性、成本较低的诊断程序:其中,实时B型超声检查最具前景。实验室检查本质上是非特异性的,对DVT诊断帮助不大:然而,它们对于监测抗凝治疗以及筛查易患血栓形成的先天性疾病至关重要。DVT的治疗基于正确使用肝素和口服抗凝剂:只有少数患者应接受溶栓药物治疗。低剂量肝素被认为是预防术后DVT最有效的治疗方法,应更广泛地使用。新型低分子量肝素已被证明在骨科手术后预防DVT方面更有效且更安全。